期刊文献+

中西医结合治疗慢性荨麻疹68例临床观察 被引量:2

下载PDF
导出
摘要 目的:观察中西医结合治疗慢性荨麻疹的临床疗效。方法:将68例慢性荨麻疹患者随机分为中西医结合治疗组和西药治疗对照组,中西医结合组应用中药自拟消荨汤结合地氯雷他定治疗,对照组单用地氯雷他定治疗,观察两组的临床疗效及复发情况。结果:中西医结合治疗组总有效率比西医治疗对照组显著增高,而复发率则明显降低。结论:中西医结合治疗慢性荨麻疹具有较好疗效,特别是在复发方面有显著优势。
作者 路斌
出处 《四川中医》 2015年第6期130-131,共2页 Journal of Sichuan of Traditional Chinese Medicine
  • 相关文献

参考文献3

  • 1赵辩.临床皮肤病学[M].第3版.南京:江苏科学技术出版社,2001.759-760.
  • 2中华医学会.临床诊疗指南皮肤病与性病分册[M].北京:人民卫生出版社,2006.141.
  • 3徐道华.第三代抗组胺药地氯雷他定[J].中国新药杂志,2005,14(12):1486-1488. 被引量:59

二级参考文献12

  • 1Juhlin L. Inhibition of cold urticaria by desloratadine[ J]. J Dermatol Treat, 2004,15( 1 ) :51 - 59,.
  • 2Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children[J]. Drug Saf, 2001,24(2) : 119 - 147.
  • 3Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in humane H1 receptors [J].Allergy, 2000,55 ( Suppl 63 ) : S279.
  • 4Lippert U, Moiler A, welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophilis by H1 and H2 receptor antagonists[J]. Exp Dermatol,2000,9(2) : 118 - 124.
  • 5Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children[J]. Curr Med Res Opin ,2004,20(12) : 1959 - 1965.
  • 6Banfield C,Gupta S, Marino M, et al. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine [ J]. Clin Pharmacokinet, 2002,41 (4) : 311 - 318.
  • 7Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis [ J ]. Allergy, 2001,56 ( Suppl 65 ) : S14 - S20.
  • 8Ring J,Hein R, Gauger A, et al. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria:a randomized,douhle-blind, placebo-controlled study [ J]. lnt J Dermatol, 2001,40(1):72-76.
  • 9Tagllalatela M, Castaldo P, Pannaccione A, et al. Cardiac ion channels and antihistamines: possible mechanisms of cadiotoxicity[J].Clin Exp Allergy, 1999,29( Suppl 3):S182- S189.
  • 10Kreutner W,Hey JA, Athes J, et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine HI receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects [ J ]. Arzneimittelforschung , 2000,50 ( 5 ) : 441 -448.

共引文献204

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部